Skip to main content

Advertisement

Table 2 Risk of development of dnDSA in different age groups

From: Age-associated decrease in de novo donor-specific antibodies in renal transplant recipients reflects changing humoral immunity

  Children < 10y Adolescent 10-19y 20-29y 30-49y 50-59y Old ≥  60y
Cumulative prevalence dnDSA 32% (6/19) 12% (3/25) 19% (5/26) 13% (15/117) 11% (11/104) 11% (12/110)
Hazard ratio, p HR 0.42 p = 0.205 HR 0.52 p = 0.312 HR 0.35 p = 0.088 HR 0.18 p = 0.014 HR 0.21 p = 0.022